Wave II Update

Thursday, February 20th 2014

Print this page

LV transduced mouse noseThe Wave 2 product (CF gene delivered by a vius) that the Consortium has developed in parallel with Wave 1 over the last decade is now progressing rapidly.

We have chosen the final form of the virus that we will take into CF patients, have learnt how to make the quantities that will be needed for the first clinical trial, and have undertaken preliminary safety studies which have not shown any unexpected problems.


DNA fragments being cut from an agarose gel exposed to UV.